LOSARK-50 Tablet is a single-drug formulation that contains Losartan Potassium, a selective angiotensin II receptor type 1 (AT1) antagonist used to effectively manage hypertension and protect vital organs from damage caused by elevated blood pressure. Each tablet delivers a 50 mg dose of Losartan, an established and globally recognized medication in the antihypertensive category.
Losartan functions by blocking the action of angiotensin II, a naturally occurring chemical in the body that narrows blood vessels and increases blood pressure. By inhibiting the binding of angiotensin II to its receptors, Losartan prevents vasoconstriction and promotes vasodilation, which reduces systemic vascular resistance and lowers blood pressure. This mechanism not only contributes to improved cardiovascular health but also decreases the workload on the heart.
In addition to treating essential hypertension, LOSARK-50 is also indicated for the management of patients with diabetic nephropathy, especially in those with type 2 diabetes and a history of proteinuria. By reducing intraglomerular pressure and protein excretion, the drug plays a critical role in preserving renal function and delaying the progression of chronic kidney disease. It is also prescribed to reduce the risk of stroke in patients with left ventricular hypertrophy and may be used as part of heart failure treatment protocols.
LOSARK-50 is typically administered once daily, either alone or in combination with other antihypertensives such as diuretics or calcium channel blockers for patients requiring multidrug therapy. The onset of action is gradual, with full antihypertensive effects typically observed within 3 to 6 weeks of consistent use. Its long duration of action allows for effective once-daily dosing, contributing to better patient compliance and consistent blood pressure control throughout the day and night.
The tablet is well tolerated in most patients, with a low incidence of side effects. Some common but usually mild adverse effects include dizziness, fatigue, nasal congestion, and gastrointestinal discomfort. Unlike ACE inhibitors, Losartan has a very low risk of causing dry cough or angioedema, making it a preferred option for patients who are intolerant to ACE inhibitors.
Caution is advised when using LOSARK-50 in patients with impaired renal or hepatic function. It is contraindicated in pregnancy, particularly during the second and third trimesters, due to potential harm to the developing fetus. In such cases, immediate discontinuation is recommended. It is also advisable to avoid concurrent use with potassium supplements or potassium-sparing diuretics, as the risk of hyperkalemia may increase.
Routine monitoring of blood pressure, renal function, and serum potassium levels is recommended during prolonged therapy. The tablet should be taken consistently at the same time each day, with or without food, to ensure stable blood levels and optimal therapeutic benefit.
LOSARK-50 is manufactured in WHO-GMP certified facilities that ensure the highest standards of pharmaceutical quality, safety, and efficacy. Its formulation meets pharmacopeial guidelines, offering uniformity in content and stability across its shelf life. Packaging is done in moisture-resistant blister packs that preserve the integrity of the product and protect it from environmental factors.
Clinically, LOSARK-50 plays a pivotal role in the long-term management of hypertension and cardiovascular disease prevention. By targeting one of the key pathways in blood pressure regulation and organ protection, it provides significant therapeutic benefits that extend beyond blood pressure control. It reduces cardiovascular morbidity, supports renal protection, and offers an excellent safety and tolerability profile.
In conclusion, LOSARK-50 Tablet is a trusted and effective choice for treating hypertension and its complications. Its ability to lower blood pressure, reduce stroke risk, and preserve kidney function makes it a valuable asset in comprehensive cardiovascular and renal care. Its once-daily dosage, high patient adherence rate, and broad clinical utility ensure its continued relevance in medical practice across diverse patient populations.
Description provided by bluepill express.
FIEO Registered
Export Ready
